{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T11:31:37Z","timestamp":1788003097816,"version":"build-2784847793"},"update-to":[{"DOI":"10.1371\/journal.pntd.0008319","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000}}],"reference-count":77,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union Seventh Framework Program","award":["305178"],"award-info":[{"award-number":["305178"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0008319","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T20:14:23Z","timestamp":1589573663000},"page":"e0008319","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Prognostic factors for mortality among patients with visceral leishmaniasis in East Africa: Systematic review and meta-analysis"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0353-7770","authenticated-orcid":true,"given":"Charles","family":"Abongomera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"van Henten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozefien","family":"Buyze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristien","family":"Verdonck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"van Griensven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,5,15]]},"reference":[{"key":"pntd.0008319.ref001","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"HW Murray","year":"2005","journal-title":"Lancet"},{"key":"pntd.0008319.ref002","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"F Chappuis","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"pntd.0008319.ref003","first-page":"557","article-title":"Global leishmaniasis update, 2006\u20132015: a turning point in leishmaniasis surveillance","volume":"38","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"pntd.0008319.ref004","unstructured":"World Health Organization. Leishmaniasis [Internet]. 2019. Available from: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/leishmaniasis"},{"key":"pntd.0008319.ref005","unstructured":"Drugs for Neglected Diseases Initiative. Leishmaniasis\u2014Disease fact sheet [Internet]. 2018. Available from: https:\/\/www.dndi.org\/wp-content\/uploads\/2018\/12\/Factsheet2018_Leishmaniasis.pdf"},{"key":"pntd.0008319.ref006","author":"World Health Organization","year":"2017","journal-title":"Leishmaniasis country profile\u20142015: South Sudan"},{"key":"pntd.0008319.ref007","author":"World Health Organization","year":"2017","journal-title":"Leishmaniasis country profile\u20142015: Sudan"},{"key":"pntd.0008319.ref008","author":"World Health Organization","year":"2017","journal-title":"Leishmaniasis country profile\u20142015: Ethiopia"},{"key":"pntd.0008319.ref009","author":"World Health Organization","year":"2017","journal-title":"Leishmaniasis country profile\u20142015: Kenya"},{"key":"pntd.0008319.ref010","author":"World Health Organization","year":"2017","journal-title":"Leishmaniasis country profile\u20142015: Uganda"},{"key":"pntd.0008319.ref011","author":"World Health Organization","year":"2017","journal-title":"Leishmaniasis country profile\u20142015: Somalia"},{"key":"pntd.0008319.ref012","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.idc.2012.03.005","article-title":"Visceral leishmaniasis","volume":"26","author":"J van Griensven","year":"2012","journal-title":"Infect Dis Clin North Am"},{"key":"pntd.0008319.ref013","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/00002030-199906180-00009","article-title":"Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B","volume":"13","author":"F Laguna","year":"1999","journal-title":"AIDS"},{"key":"pntd.0008319.ref014","doi-asserted-by":"crossref","first-page":"766","DOI":"10.4269\/ajtmh.1999.61.766","article-title":"High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients","volume":"61","author":"J Delgado","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0008319.ref015","unstructured":"World Health Organization. Control of the leishmaniases. [Internet]. WHO Technical Report Series. 2010. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/44412\/1\/WHO_TRS_949_eng.pdf"},{"key":"pntd.0008319.ref016","doi-asserted-by":"crossref","first-page":"e2869","DOI":"10.1371\/journal.pntd.0002869","article-title":"Visceral Leishmaniasis and HIV coinfection in East Africa","volume":"8","author":"E Diro","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008319.ref017","first-page":"53","article-title":"Visceral Leishmaniasis and HIV co-infection in patients admitted to Gondar university hospital, northwest Ethiopia","volume":"21","author":"G Mengistu","year":"2007","journal-title":"Ethiop J Heal Dev"},{"key":"pntd.0008319.ref018","first-page":"1619","article-title":"The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults","volume":"100","author":"WA Knaus","year":"1991","journal-title":"Chest"},{"key":"pntd.0008319.ref019","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1097\/ALN.0b013e3181fc6e0a","article-title":"Prediction of postoperative pulmonary complications in a population-based surgical cohort","volume":"113","author":"J Canet","year":"2010","journal-title":"Anesthesiology"},{"key":"pntd.0008319.ref020","doi-asserted-by":"crossref","first-page":"e2982","DOI":"10.1371\/journal.pntd.0002982","article-title":"Risk Factors for Adverse Prognosis and Death in American Visceral Leishmaniasis: A Meta-analysis","volume":"8","author":"VS Belo","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008319.ref021","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1365-3156.2010.02550.x","article-title":"Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia","volume":"15","author":"Z Hurissa","year":"2010","journal-title":"Trop Med Int Health"},{"key":"pntd.0008319.ref022","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1086\/381203","article-title":"Conflict and Kala-Azar: Determinants of Adverse Outcomes of Kala-Azar among Patients in Southern Sudan","volume":"38","author":"S Collin","year":"2004","journal-title":"Clin Infect Dis"},{"key":"pntd.0008319.ref023","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-3156.2009.02305.x","article-title":"Risk factors for in-hospital mortality of visceral leishmaniasis patients in eastern Uganda","volume":"14","author":"Y Mueller","year":"2009","journal-title":"Trop Med Int Health"},{"key":"pntd.0008319.ref024","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4269\/ajtmh.2009.81.373","article-title":"Natural history of a visceral leishmaniasis outbreak in highland Ethiopia","volume":"81","author":"M Herrero","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0008319.ref025","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.1365-3156.2003.01088.x","article-title":"Visceral leishmaniasis and HIV in Tigray, Ethiopia","volume":"8","author":"S Lyons","year":"2003","journal-title":"Trop Med Int Heal"},{"key":"pntd.0008319.ref026","doi-asserted-by":"crossref","first-page":"664","DOI":"10.7326\/0003-4819-124-7-199604010-00007","article-title":"Epidemic visceral leishmaniasis in southern Sudan: Treatment of severely debilitated patients under wartime conditions and with limited resources","volume":"124","author":"J Seaman","year":"1996","journal-title":"Ann Intern Med"},{"key":"pntd.0008319.ref027","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"A Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"pntd.0008319.ref028","article-title":"International prospective register of systematic reviews A systematic review of risk factors for mortality in visceral leishmaniasis patients in East Africa","author":"Charles Abongomera","year":"2016"},{"key":"pntd.0008319.ref029","first-page":"427","article-title":"Research and Reporting Methods Annals of Internal Medicine Assessing Bias in Studies of Prognostic Factors","volume":"144","author":"JA Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"pntd.0008319.ref030","doi-asserted-by":"crossref","first-page":"e1001671","DOI":"10.1371\/journal.pmed.1001671","article-title":"Improving the Transparency of Prognosis Research: The Role of Reporting, Data Sharing, Registration, and Protocols","volume":"11","author":"G Peat","year":"2014","journal-title":"PLoS Med"},{"key":"pntd.0008319.ref031","unstructured":"The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions. 2011."},{"key":"pntd.0008319.ref032","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised","volume":"342","author":"JAC Sterne","year":"2011","journal-title":"Br Med J"},{"key":"pntd.0008319.ref033","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ijgo.12332","article-title":"Cross-\u00adsectional study of the case\u2013fatality rate among patients with visceral leishmaniasis infections during pregnancy in Sudan","volume":"140","author":"GK Adam","year":"2017","journal-title":"Int J Gynecol Obstet"},{"key":"pntd.0008319.ref034","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/trstmh\/trx023","article-title":"Does timing of antiretroviral treatment influence treatment outcomes of visceral leishmaniasis in Northwest Ethiopia?","volume":"111","author":"EM Aderie","year":"2017","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0008319.ref035","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/tmi.12603","article-title":"Sodium stibogluconate and paromomycin for treating visceral leishmaniasis under routine conditions in eastern Sudan","volume":"20","author":"AM Atia","year":"2015","journal-title":"Trop Med Int Heal"},{"key":"pntd.0008319.ref036","doi-asserted-by":"crossref","first-page":"e2875","DOI":"10.1371\/journal.pntd.0002875","article-title":"High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia","volume":"8","author":"E Diro","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008319.ref037","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.trstmh.2010.07.007","article-title":"Safety and effectiveness of meglumine antimoniate in the treatment of Ethiopian visceral leishmaniasis patients with and without HIV co-infection","volume":"104","author":"W Hailu","year":"2010","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0008319.ref038","doi-asserted-by":"crossref","first-page":"e0005921","DOI":"10.1371\/journal.pntd.0005921","article-title":"A clinical severity scoring system for visceral leishmaniasis in immunocompetent patients in South Sudan","volume":"11","author":"SS K\u00e4mink","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008319.ref039","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/00034983.1998.11813274","article-title":"Treatment of visceral leishmaniasis with sodium stibogluconate in Sudan: management of those who do not respond","volume":"92","author":"EAG Khalil","year":"1998","journal-title":"Ann Trop Med Parasitol"},{"key":"pntd.0008319.ref040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s40261-016-0481-0","article-title":"Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme","volume":"37","author":"R Kimutai","year":"2017","journal-title":"Clin Drug Investig"},{"key":"pntd.0008319.ref041","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4269\/ajtmh.1979.28.15","article-title":"Clinical and laboratory features and treatment of visceral leishmaniasis in hospitalized patients in Northwestern Ethiopia","volume":"28","author":"M Maru","year":"1979","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0008319.ref042","first-page":"199","article-title":"Kala-azar among labour migrants in metema-humera region of ethiopia","volume":"30","author":"B Mengesha","year":"1978","journal-title":"Trop Geogr Med"},{"key":"pntd.0008319.ref043","doi-asserted-by":"crossref","first-page":"21","DOI":"10.17352\/2455-5363.000010","article-title":"Prevalence of Hepatitis B, Hepatitis C, HIV and Malaria Co Infection among Patients Infected with Visceral Leishmaniasis in Gedarif, Eastern Sudan","volume":"2","author":"HB Mohammed","year":"2016","journal-title":"Glob J Infect Dis Clin Res"},{"key":"pntd.0008319.ref044","first-page":"1","article-title":"Current Research on HIV\/AIDS Seroprevalence of HIV Infection among Visceral Leishmaniasis Patients in Gadarif, Eastern Sudan","volume":"2016","author":"SM Omar","year":"2016","journal-title":"Curr Res HIV\/AIDS"},{"key":"pntd.0008319.ref045","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1093\/cid\/cir674","article-title":"Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence","volume":"53","author":"K Ritmeijer","year":"2011","journal-title":"Clin Infect Dis"},{"key":"pntd.0008319.ref046","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/tmi.12238","article-title":"Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: How effective is treatment for this neglected disease?","volume":"19","author":"NA Salih","year":"2014","journal-title":"Trop Med Int Heal"},{"key":"pntd.0008319.ref047","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/tropej\/38.1.17","article-title":"Clinical aspects of kala-azar in children from the Sudan: a comparison with the disease in adults","volume":"38","author":"EE Zijlstra","year":"1992","journal-title":"J Trop Pediatr"},{"key":"pntd.0008319.ref048","first-page":"1","article-title":"The Emerging Questions from the Current Epidemiology of Visceral Leishmaniasis in South Sudan: A Cross-sectional Study Design","volume":"2","author":"K Boateng","year":"2017","journal-title":"J Emerg Infect Dis"},{"key":"pntd.0008319.ref049","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.1985.34.702","article-title":"Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate)","volume":"34","author":"JD Chulay","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0008319.ref050","doi-asserted-by":"crossref","first-page":"e705","DOI":"10.1371\/journal.pntd.0000705","article-title":"Visceral leishmaniasis relapse in Southern Sudan (1999\u20132007): a retrospective study of risk factors and trends","volume":"4","author":"S Gorski","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008319.ref051","first-page":"21","article-title":"Clinical, haematological and parasitological response to treatment of visceral leishmaniasis in Kenya. A study of 64 patients","volume":"36","author":"PA Kager","year":"1984","journal-title":"Trop Geogr Med"},{"key":"pntd.0008319.ref052","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4269\/ajtmh.2007.77.89","article-title":"Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy","volume":"77","author":"Y Melaku","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0008319.ref053","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1179\/136485908X252142","article-title":"Safety and effectiveness of amphotericin B deoxycholate for the treatment of visceral leishmaniasis in Uganda","volume":"102","author":"Y Mueller","year":"2008","journal-title":"Ann Trop Med Parasitol"},{"key":"pntd.0008319.ref054","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4269\/ajtmh.13-0150","article-title":"Clinical epidemiology, diagnosis and treatment of visceral leishmaniasis in the Pokot endemic area of Uganda and Kenya","volume":"90","author":"YK Mueller","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0008319.ref055","first-page":"609","article-title":"Royal Society of Tropical Medicine and Hygiene joint meeting with M\u00e9decins Sans Fronti\u00e8res at Manson House, London, 20 March 2003: field research in humanitarian medical programmes. M\u00e9decins Sans Fronti\u00e8res interventions against kala-azar in the Sudan, 19","volume":"97","author":"K Ritmeijer","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0008319.ref056","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1186\/s12879-016-1746-1","article-title":"Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia","volume":"16","author":"A Tamiru","year":"2016","journal-title":"BMC Infect Dis"},{"key":"pntd.0008319.ref057","first-page":"1","article-title":"Visceral leishmaniasis and HIV co-infection in Northwest Ethiopia: Antiretroviral treatment and burden of disease amongst patients enrolled in HIV care","author":"J van Griensven","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0008319.ref058","doi-asserted-by":"crossref","first-page":"e1617","DOI":"10.1371\/journal.pntd.0001617","article-title":"Prevalence, features and risk factors for malaria co-infections amongst visceral leishmaniasis patients from Amudat Hospital, Uganda","volume":"6","author":"E van den Bogaart","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008319.ref059","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/1471-2458-13-332","article-title":"Concomitant malaria among visceral leishmaniasis in-patients from Gedarif and Sennar States, Sudan: a retrospective case-control study","volume":"13","author":"E van den Bogaart","year":"2013","journal-title":"BMC Public Health"},{"key":"pntd.0008319.ref060","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/505217","article-title":"A Comparison of Miltefosine and Sodium Stibogluconate for Treatment of Visceral Leishmaniasis in an Ethiopian Population with High Prevalence of HIV Infection","volume":"43","author":"K Ritmeijer","year":"2006","journal-title":"Clin Infect Dis"},{"key":"pntd.0008319.ref061","doi-asserted-by":"crossref","first-page":"e709","DOI":"10.1371\/journal.pntd.0000709","article-title":"Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial","volume":"4","author":"A Hailu","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008319.ref062","first-page":"481","article-title":"Comparative study of liposomal amphotericin B (ambisome) and sodium stibogluconate in the treatment of kala-azar in the sudan","volume":"75","author":"E.A.G. Khalil","year":"1998","journal-title":"East Afr Med J"},{"key":"pntd.0008319.ref063","first-page":"388","article-title":"Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya","volume":"79","author":"E Moore","year":"2001","journal-title":"Bull World Health Organ"},{"key":"pntd.0008319.ref064","doi-asserted-by":"crossref","first-page":"e1674","DOI":"10.1371\/journal.pntd.0001674","article-title":"Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial","volume":"6","author":"A Musa","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008319.ref065","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0035-9203(01)90110-5","article-title":"Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome","volume":"95","author":"K Ritmeijer","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0008319.ref066","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/infdis\/168.3.715","article-title":"Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone","volume":"168","author":"J. Seaman","year":"1993","journal-title":"J Infect Dis"},{"key":"pntd.0008319.ref067","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/clinids\/21.1.188","article-title":"Liposomal amphotericin B (AmBisome) in the treatment of complicated kala-azar under field conditions","volume":"21","author":"J Seaman","year":"1995","journal-title":"Clin Infect Dis"},{"key":"pntd.0008319.ref068","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1365-3156.2000.00555.x","article-title":"A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan","volume":"5","author":"H Veeken","year":"2000","journal-title":"Trop Med Int Heal"},{"key":"pntd.0008319.ref069","doi-asserted-by":"crossref","first-page":"e0004880","DOI":"10.1371\/journal.pntd.0004880","article-title":"Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial","volume":"10","author":"M Wasunna","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008319.ref070","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0035-9203(93)90140-L","article-title":"The treatment of kala-azar in the Sudan with sodium stibogluconate: a randomized trial of three dosage regimens","volume":"87","author":"EE Zijlstra","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0008319.ref071","doi-asserted-by":"crossref","first-page":"e0178996","DOI":"10.1371\/journal.pone.0178996","article-title":"Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia","volume":"12","author":"C Abongomera","year":"2017","journal-title":"PLoS One"},{"key":"pntd.0008319.ref072","doi-asserted-by":"crossref","first-page":"e0006527","DOI":"10.1371\/journal.pntd.0006527","article-title":"The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study","volume":"12","author":"C Abongomera","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008319.ref073","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijid.2016.08.021","article-title":"Trend in cumulative cases and mortality rate among visceral leishmaniasis patients in Eastern Sudan: a 14-year registry, 2002\u20132015","volume":"51","author":"GK Adam","year":"2016","journal-title":"Int J Infect Dis"},{"key":"pntd.0008319.ref074","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/ije\/25.4.862","article-title":"The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: course and impact from 1984 to 1994","volume":"25","author":"J Seaman","year":"1996","journal-title":"Int J Epidemiol"},{"key":"pntd.0008319.ref075","doi-asserted-by":"crossref","first-page":"e0005921","DOI":"10.1371\/journal.pntd.0005921","article-title":"A clinical severity scoring system for visceral leishmaniasis in immunocompetent patients in South Sudan","volume":"11","author":"SS K\u00e4mink","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0008319.ref076","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/361058","article-title":"Bacterial Sepsis in Patients with Visceral Leishmaniasis in Northwest Ethiopia","volume":"2014","author":"M Endris","year":"2014","journal-title":"Biomed Res Int"},{"key":"pntd.0008319.ref077","unstructured":"Infectious Diseases Data Observatory. Infectious Diseases Data Observatory (IDDO): Visceral leishmaniasis [Internet]. online. 2019 [cited 2019 Jul 2]. Available from: https:\/\/www.iddo.org\/research-themes\/visceral-leishmaniasis"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0008319","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T17:46:59Z","timestamp":1590688019000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008319"}},"subtitle":[],"editor":[{"given":"Guilherme L.","family":"Werneck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,5,15]]},"references-count":77,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0008319","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0008319","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,15]]}}}